CVS Health reported Q2 2024 total revenues increased 2.6% to $91.2 billion, driven by growth in Health Care Benefits and Pharmacy & Consumer Wellness segments, partially offset by declines in Health Services. Net income attributable to CVS Health decreased 6.9% to $1.77 billion, while diluted EPS was $1.41 compared to $1.48 in Q2 2023.The Health Care Benefits segment saw revenues rise 21.4% to $32.5 billion, though its medical benefit ratio increased to 89.6% from 86.2% due to higher utilization in Medicare Advantage and Medicaid. The Pharmacy & Consumer Wellness segment's revenues grew 3.7% to $29.8 billion, driven by increased prescription volume, while the Health Services segment revenues declined 8.8% to $42.2 billion following the loss of a large client.The company issued $5 billion in senior notes in May 2024 for general corporate purposes and repurchased 39.7 million shares for approximately $3 billion during H1 2024. CVS Health maintained its retail presence with over 9,000 locations and continued serving approximately 90 million pharmacy benefit manager plan members, though facing ongoing challenges from elevated Medicare utilization and Medicaid cost pressures.

CVS Health reported Q2 2024 total revenues increased 2.6% to $91.2 billion, driven by growth in Health Care Benefits and Pharmacy & Consumer Wellness segments, partially offset by declines in Health Services. Net income attributable to CVS Health decreased 6.9% to $1.77 billion, while diluted EPS was $1.41 compared to $1.48 in Q2 2023.The Health Care Benefits segment saw revenues rise 21.4% to $32.5 billion, though its medical benefit ratio increased to 89.6% from 86.2% due to higher utilization in Medicare Advantage and Medicaid. The Pharmacy & Consumer Wellness segment's revenues grew 3.7% to $29.8 billion, driven by increased prescription volume, while the Health Services segment revenues declined 8.8% to $42.2 billion following the loss of a large client.The company issued $5 billion in senior notes in May 2024 for general corporate purposes and repurchased 39.7 million shares for approximately $3 billion during H1 2024. CVS Health maintained its retail presence with over 9,000 locations and continued serving approximately 90 million pharmacy benefit manager plan members, though facing ongoing challenges from elevated Medicare utilization and Medicaid cost pressures.